Eventide Asset Management’s Inspire Medical Systems INSP Stock Holding History
Bought
Maintained
Sold
Other funds holding INSP
DM
Eventide Asset Management's INSP Position: Q1 2026 in Review
Eventide Asset Management sold out of Inspire Medical Systems (INSP) in Q1 2026, closing a stake of 440,205 shares — an estimated $40.6M sold.
Eventide Asset Management first reported a position in INSP in Q2 2022 and held it in 15 quarters. The position peaked at $48.8M in Q1 2025. 301 funds tracked by Wall St. Rank hold INSP as of Q1 2026.
- Eventide Asset Management reported no remaining Inspire Medical Systems position as of Q1 2026 after selling out during the quarter.
- Eventide Asset Management sold 440,205 Inspire Medical Systems shares in Q1 2026, an estimated $40.6M.
- Eventide Asset Management first reported a position in Inspire Medical Systems in Q2 2022 and held it in 15 quarters.
- Eventide Asset Management's Inspire Medical Systems position peaked at $48.8M in Q1 2025.
- 301 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q1 2026.
Based on Eventide Asset Management's 13F filing for Q1 2026, filed 15 May 2026.